Quest Diagnostics Declares Quarterly Cash Dividend
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) announced that its Board of Directors has declared a quarterly cash dividend of $0.75 per share. The dividend will be payable on January 29, 2025 to shareholders of record as of January 14, 2025. This announcement demonstrates the company's continued commitment to returning value to shareholders through regular dividend payments.
Positive
- Maintains consistent quarterly dividend payment of $0.75 per share
- Demonstrates financial stability and commitment to shareholder returns
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DGX declined 0.71%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from the world's largest database of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302303423.html
SOURCE Quest Diagnostics